Medical Oncology

Papers
(The TQCC of Medical Oncology is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.51
In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells41
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs40
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group35
Sarcoid-like reaction in cases treated by checkpoint inhibitors29
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter 26
Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia24
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation21
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine21
Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis21
Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway21
Computational study on novel natural inhibitors targeting BCL221
Identification of molecular heterogeneity of hepatocellular carcinoma based on immune gene expression signatures20
Protein interacting with C-kinase 1 is involved in epithelial-mesenchymal transformation and suppresses progress of gastric cancer19
Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma19
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity19
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways18
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis17
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma17
Identification of key genes in the tumor microenvironment of lung adenocarcinoma16
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells16
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance16
Vaccination of cancer patients against COVID-19: towards the end of a dilemma16
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer16
Exosomes and cancer: from molecular mechanisms to clinical applications15
Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools15
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer15
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model14
Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor14
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies13
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?13
Cancer induced bone pain: current management and future perspectives13
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors13
Correction to: Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes12
Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma12
Cancer stem cell characteristics and their potential as therapeutic targets12
CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction12
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance12
The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma12
Adoptive cell therapy of patient-derived renal cell carcinoma xenograft model with IL-15-induced γδT cells11
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer11
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway11
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer11
Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions11
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?11
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?11
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radio11
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a mu11
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives10
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer10
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies10
Oncology: etymology of the term10
Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy10
The immunomodulatory effects of Candida albicans isolated from the normal gastrointestinal microbiome of the elderly on colorectal cancer10
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients10
How should we manage non-small-cell lung cancer “not-otherwise-specified”?10
Immunotherapy and predictive immunologic profile: the tip of the iceberg10
0.031909942626953